Skip to main content

Fenofibrate (International)

In the US, Fenofibrate (fenofibrate systemic) is a member of the drug class fibric acid derivatives and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IV - Elevated VLDL, Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL and Hypertriglyceridemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AB05

CAS registry number (Chemical Abstracts Service)

0049562-28-9

Chemical Formula

C20-H21-Cl-O4

Molecular Weight

361

Therapeutic Category

Lipid lowering: Fibrate

Chemical Names

1-Metyletyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-metylpropanoate (Ph. Eur., BP)

Isopropyl 2-[p-(p-chlorobenzoyl)phenoxy]-2-metylpropionate (WHO)

Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-metyl-, 1-metyletyl ester

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.